Domperidone for Gastroparesis in Solid Organ Transplantation
NCT00552422 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2015-07-10
Summary
The purpose of this study is to examine the clinical response to domperidone in solid organ transplant recipients with gastroparesis.
Conditions
- Gastroparesis
- Gastroesophageal Reflux
Interventions
- DRUG
-
domperidone
10mg orally four times per day
Sponsors & Collaborators
-
David J. Lederer, M.D.
lead OTHER
Principal Investigators
-
David J Lederer, M.D. · Columbia University
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-03-31
- Primary Completion
- 2010-09-30
- Completion
- 2010-09-30
Countries
- United States
Study Locations
More Related Trials
-
Adequate Definition of Delayed Graft Function in Living and Deceased Donor Kidney Transplantation
NCT02080117 ·Status: COMPLETED
-
Delayed Infusion of DCreg in Living Donor Liver Transplantation
NCT04208919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
DCreg in Living Donor Liver Transplantation
NCT03164265 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Frequency and Risk Factors of Delayed Graft Function
NCT03555513 ·Status: COMPLETED
-
Donor-Derived Cell-free DNA to DETect REjection in Cardiac Transplantation
NCT05081739 ·Status: WITHDRAWN ·Phase: NA
-
Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction
NCT01715883 ·Status: TERMINATED ·Phase: PHASE2
-
Donor Dopamine and Initial Graft Function
NCT00115115 ·Status: COMPLETED ·Phase: PHASE4
-
Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation
NCT00552357 ·Status: RECRUITING
-
Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction
NCT03359863 ·Status: COMPLETED ·Phase: PHASE2
-
Intracoronary Bradykinin Mediated t-PA Release in Heart Transplant Recipients
NCT00780377 ·Status: WITHDRAWN ·Phase: NA
-
Trajectories of FEV1 After Lung Transplantation
NCT05934617 ·Status: ENROLLING_BY_INVITATION
-
Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation
NCT00425126 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant
NCT00886262 ·Status: COMPLETED ·Phase: NA
-
Preventing Delayed Graft Function in Kidney Transplant Patients
NCT06724211 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Angiotensin II in Liver Transplantation
NCT04901169 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Heart Transplant and Primary Transplant Dysfunction: a Retrospective Analysis of the Strasbourg Experience
NCT03156894 ·Status: UNKNOWN
-
Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion
NCT00497926 ·Status: TERMINATED ·Phase: PHASE2
-
Heart Transplantation Utilizing NRP DCD
NCT05243914 ·Status: TERMINATED
-
Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance
NCT03090646 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Left Ventricular Diastolic Dysfunction in Kidney Recipients
NCT02322567 ·Status: COMPLETED
-
Normothermic Machine Perfusion (NMP) Versus Static Cold Storage (SCS) in Human Kidney Transplantation
NCT05031052 ·Status: RECRUITING ·Phase: NA
-
StOPping Hypertension and imprOving Children's Lives After KidnEy TranSplantation
NCT06589947 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations
NCT06367205 ·Status: RECRUITING ·Phase: NA
-
Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media
NCT03099434 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation
NCT00457847 ·Status: RECRUITING